Sunday , April 22 2018
Home / Letter From The Editor / Feb. 24, 2018

Feb. 24, 2018

Feb 24, 2018
 

Every week we bring you great information on the latest details of new drugs and new studies on old drugs. In fact in 2018 alone we have had over 20 articles on pharmaceuticals.

This plethora of choices and information often overwhelms even the most astute clinician, and when you add in things like comorbidities, prescription cost, drug coverage and the patient’s ability to pay, selecting a proper regimen is totally overwhelming.

For the past 6 weeks we have been featuring a program called GlucosePath. Our publisher, Steve Freed, has worked with the creators to bring you a unique opportunity. He has convinced the developers of the program that recently received 1st place in the  American Association of Clinical Endocrinologists’ annual conference and poster competition, to let you beta test the program at absolutely no charge. All you have to do is send an email to Steve at publisher@diabetesincontrol.com with your background and purpose for using the software and he will set you up to take advantage of this awesome program.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief